Ingenix valuation, funding and investors
Ingenix works in multimodal AI platform development, based in Warsaw, Poland. Founded in 2023, it has about 41 employees.
- Last round
- Seed · $15.0M · Jun 2026
- Valuation at last round
- $92.2M · implied
- Headcount
- 41 · growing
- Grade
- C
- Founded
- 2023
Ingenix valuation today
VCMC values Ingenix at $122M today, with a range of $66.9M to $269M and a grade of C. The valuation starts from its last funding round, a seed round in Jun 2026.
Valuation by date (49 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2023 | $12.8M | $4.65M – $35.1M | $14.0M (+9%) | before first round | – | unknown | D | 0% |
| 1 Feb 2023 | $12.9M | $4.69M – $35.4M | $14.1M (+9%) | before first round | – | unknown | D | 0% |
| 1 Mar 2023 | $13.0M | $4.72M – $35.6M | $14.2M (+9%) | before first round | – | unknown | D | 0% |
| 1 Apr 2023 | $13.1M | $4.75M – $35.9M | $14.3M (+9%) | before first round | – | unknown | D | 0% |
| 1 May 2023 | $13.2M | $4.79M – $36.1M | $14.4M (+9%) | before first round | – | unknown | D | 0% |
| 1 Jun 2023 | $13.3M | $4.83M – $36.4M | $14.5M (+9%) | before first round | – | unknown | D | 0% |
| 1 Jul 2023 | $13.4M | $4.86M – $36.7M | $14.6M (+9%) | before first round | – | unknown | D | 0% |
| 1 Aug 2023 | $13.5M | $4.90M – $36.9M | $14.6M (+8%) | before first round | – | unknown | D | 0% |
| 1 Sep 2023 | $13.6M | $4.93M – $37.2M | $14.6M (+8%) | before first round | – | unknown | D | 0% |
| 1 Oct 2023 | $13.6M | $4.97M – $37.5M | $14.6M (+7%) | before first round | – | unknown | D | 0% |
| 1 Nov 2023 | $13.8M | $5.01M – $37.8M | $14.6M (+6%) | before first round | – | unknown | D | 0% |
| 1 Dec 2023 | $13.9M | $5.04M – $38.1M | $14.6M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2024 | $14.0M | $5.08M – $38.3M | $14.6M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2024 | $14.1M | $5.12M – $38.6M | $14.6M (+4%) | before first round | – | unknown | D | 0% |
| 1 Mar 2024 | $9.06M | $3.30M – $24.9M | $9.33M (+3%) | before first round | 1 | unknown | D | 0% |
| 1 Apr 2024 | $9.13M | $3.32M – $25.1M | $9.33M (+2%) | before first round | 1 | unknown | D | 0% |
| 1 May 2024 | $9.20M | $3.35M – $25.3M | $9.33M (+1%) | before first round | 1 | unknown | D | 0% |
| 1 Jun 2024 | $9.27M | $3.37M – $25.5M | $9.33M (+1%) | before first round | 1 | unknown | D | 0% |
| 1 Jul 2024 | $13.0M | $4.75M – $35.8M | $13.0M (0%) | before first round | 8 | unknown | D | 0% |
| 1 Aug 2024 | $13.0M | $4.75M – $35.8M | $13.0M (0%) | before first round | 8 | unknown | D | 0% |
| 1 Sep 2024 | $13.0M | $4.75M – $35.8M | $13.0M (0%) | before first round | 8 | unknown | D | 0% |
| 1 Oct 2024 | $13.0M | $4.75M – $35.8M | $13.0M (0%) | before first round | 8 | unknown | D | 0% |
| 1 Nov 2024 | $13.3M | $4.84M – $36.5M | $13.3M (0%) | before first round | 9 | unknown | D | 0% |
| 1 Dec 2024 | $13.3M | $4.84M – $36.5M | $13.3M (0%) | before first round | 9 | unknown | D | 0% |
| 1 Jan 2025 | $13.3M | $4.84M – $36.5M | $13.3M (0%) | before first round | 9 | unknown | D | 0% |
| 1 Feb 2025 | $13.3M | $4.84M – $36.5M | $13.3M (0%) | before first round | 9 | unknown | D | 0% |
| 1 Mar 2025 | $13.3M | $4.84M – $36.5M | $13.3M (0%) | before first round | 9 | unknown | D | 0% |
| 1 Apr 2025 | $13.3M | $4.84M – $36.5M | $13.3M (0%) | before first round | 9 | unknown | D | 0% |
| 9 Apr 2025 | $60.7M | $39.8M – $184M | $121M (+100%) | after a round | 9 | unknown | C | 0% |
| 1 May 2025 | $63.3M | $39.8M – $184M | $121M (+91%) | after a round | 9 | unknown | C | 0% |
| 1 Jun 2025 | $67.1M | $39.8M – $184M | $121M (+81%) | after a round | 9 | unknown | C | 0% |
| 1 Jul 2025 | $71.0M | $39.8M – $184M | $121M (+71%) | after a round | 9 | unknown | C | 0% |
| 1 Aug 2025 | $75.3M | $39.8M – $184M | $121M (+61%) | after a round | 22 | growing | C | 0% |
| 1 Sep 2025 | $79.9M | $39.8M – $184M | $121M (+52%) | after a round | 22 | growing | C | 0% |
| 1 Oct 2025 | $85.3M | $40.6M – $188M | $123M (+45%) | after a round | 24 | growing | C | 0% |
| 1 Nov 2025 | $90.7M | $40.6M – $188M | $123M (+36%) | after a round | 24 | growing | C | 0% |
| 1 Dec 2025 | $98.3M | $42.0M – $194M | $128M (+30%) | after a round | 28 | growing | C | 0% |
| 1 Jan 2026 | $105M | $42.0M – $194M | $128M (+22%) | after a round | 28 | growing | C | 0% |
| 1 Feb 2026 | $112M | $42.0M – $194M | $128M (+14%) | after a round | 28 | growing | C | 0% |
| 1 Mar 2026 | $118M | $42.0M – $194M | $128M (+8%) | after a round | 28 | growing | C | 0% |
| 1 Apr 2026 | $126M | $42.0M – $194M | $128M (+1%) | after a round | 28 | growing | C | 0% |
| 1 May 2026 | $133M | $43.9M – $203M | $133M (0%) | after a round | 34 | growing | C | 0% |
| 1 Jun 2026 | $133M | $44.1M – $203M | $133M (0%) | after a round | 34 | growing | C | 0% |
| 4 Jun 2026 | $92.4M | $65.0M – $262M | $184M (+100%) | after a round | 34 | growing | C | 0% |
| 1 Jul 2026 | $97.2M | $65.0M – $262M | $184M (+90%) | after a round | 34 | growing | C | 0% |
| 1 Aug 2026 | $103M | $65.0M – $262M | $184M (+79%) | after a round | 36 | growing | C | 0% |
| 1 Sep 2026 | $110M | $66.1M – $266M | $188M (+71%) | after a round | 39 | growing | C | 0% |
| 1 Oct 2026 | $117M | $66.9M – $269M | $190M (+62%) | after a round | 41 | growing | C | 0% |
| 24 Oct 2026 | $122M | $66.9M – $269M | $190M (+55%) | after a round | 41 | growing | C | 0% |
Key facts about Ingenix
- Founded
- 2023
- Headquarters
- Warsaw, Poland
- Employees
- about 41 +71% in a year
- Total raised
- $25M
- Funding rounds
- 2
- Last round
- Seed Jun 2026
Ingenix was founded in 2023 by Adam Dancewicz and Piotr Surma.
Ingenix funding history
Ingenix has 2 funding rounds on record, from Apr 2025 to Jun 2026, $25M in total. None disclosed a valuation.
Seed 3 Jun 2026
Led by Sofinnova Partners; with Inovo, OTB Ventures.
Sources: prnewswire.com, finsmes.com, ddw-online.com and 2 more
$15M
Seed 8 Apr 2025
Led by Inovo; with OTB Ventures, International Finance Corporation.
Sources: techfundingnews.com, therecursive.com, european-biotechnology.com
$9.9M
Ingenix investors
4 investors have backed Ingenix; Inovo and Sofinnova Partners led at least one round.
What Ingenix does
Ingenix works in tech companies, with 14 recorded offerings and customers in pharmaceuticals and biotechnology.
Ingenix.ai Sp z o.o. is a Polish private company engaged in the development of multimodal and multiscale generative AI solutions for clinical development. The company provides a platform that integrates biological and medical knowledge across multiple data modalities, including text, graphics, bioimaging, 3D structures, sequences, and time series, to support drug discovery and clinical trial simulation. Ingenix's platform is used by pre-clinical development teams, strategy teams, and clinical development teams to optimize drug candidate selection, research and development investments, and clinical endpoint predictions. The company also offers biotechnology research and information technology services, with a focus on advancing AI-based drug discovery and clinical trial simulation.
Description from Veridion's company data.
Products and services
- Multimodal AI Platform Development
- Clinical Trial Simulation and Prediction
- Drug Candidate Optimization Services
- Clinical Endpoint Prediction and Insights
- Adverse Event Prediction and Insights
- Biological Data Integration Solutions
- Genomic and Transcriptomic Data Analysis
- Proteomic and Imaging Data Analysis
- Phenotypic Data Analysis Services
- AI-Driven Research Support Services
- Clinical Development Consulting Services
- Multiscale AI Model Development
- Natural Language AI Query Services
- Biotechnology Information Services
Markets
- Pharmaceuticals
- Biotechnology
Technology
- Multimodal Generative AI for Clinical Development
- Multiscale AI Simulation for Clinical Trials
- Chain-of-Thought Prompting for AI Co-Pilot
- Biomedical Knowledge Integration for AI Models
- AI-Driven Clinical Trial Optimization
- AI-Powered Drug Interaction Prediction
- Digital Twin-Based Clinical Simulation
Business model
- Business-to-Business
- Software-as-a-Service
Industry codes (NAICS)
- 513210 Software Publishers 60% match
- 541714 Research and Development in Biotechnology (except Nanobiotechnology) 40% match
Questions about Ingenix
What is Ingenix worth?
Valuation $122M (range $66.9M to $269M), as of 24 Oct 2026.
Has Ingenix raised money?
Ingenix has 2 funding rounds on record, from Apr 2025 to Jun 2026, $25M in total. None disclosed a valuation.
Who has invested in Ingenix?
Inovo, Sofinnova Partners, OTB Ventures and International Finance Corporation. Lead investors include Inovo and Sofinnova Partners.
How many people work at Ingenix?
About 41, up 71% over the last year. Headcount grew from 1 in Mar 2024 to 41 in Sep 2026.
What does Ingenix do?
Ingenix works in tech companies, with 14 recorded offerings and customers in pharmaceuticals and biotechnology. Its main offerings are multimodal AI platform development, clinical trial simulation and prediction and drug candidate optimization services.
When was Ingenix founded, and where is it based?
Ingenix was founded in 2023 and is based in Warsaw, Poland. It has about 41 employees, up 71% over the last year.